Skip to main content
Rebecca Morris

Rebecca Morris

NIHR Maudsley BRC PhD Student

Contact details

Biography

Rebecca Morris is an NIHR Maudsley BRC PhD student in the Department of Psychological Medicine at King's College London, supervised by Dr. Hubertus Himmerich, Professor Janet Treasure, and Dr. Johanna Keeler.

Rebecca's research is part of the EDEN study, which investigates the use of ketamine to treat depression in adults with anorexia nervosa. Using qualitative methods, including interviews and digital diaries, Rebecca explores participants' experiences of the study and the treatment, alongside clinician perspectives on ketamine use for treatment in this population. She is also interested in how ketamine can be used safely and effectively in people with anorexia nervosa by considering how treatment and population factors may inform ED-specific approaches.

Rebecca previously completed an MSc in Psychiatric Research at King's College London, where she was awarded the Prof. Shitij Kapur Prize for Innovation. She also holds a First Class Honours BSc in Psychology from the University of Greenwich. 

Research Interests

  • Eating disorders
  • Anorexia Nervosa
  • Qualitative research
  • Classic and atypical psychedelics

Research Groups

Centre for Research in Eating and Weight Disorders

    Research

    Untitled design-15
    Centre for Research in Eating And Weight Disorders (CREW)

    The Centre for Research in Eating And Weight Disorders aims to find out more about the neurobiological, genetic and psychological causes and consequences of anorexia nervosa, bulimia nervosa and other eating disorders, and to use that knowledge to develop new and better treatments.

      Research

      Untitled design-15
      Centre for Research in Eating And Weight Disorders (CREW)

      The Centre for Research in Eating And Weight Disorders aims to find out more about the neurobiological, genetic and psychological causes and consequences of anorexia nervosa, bulimia nervosa and other eating disorders, and to use that knowledge to develop new and better treatments.